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SUPPLEMENTARY TABLE S1: Primers Used for Mutational Analysis of SLC4A11. 
Exon(s) 
Primer sequence (5’-3’) Annealing 
temperature 
(°C) 
Amplicon 
size (bp) 
Forward Reverse 
1 CCTAGCAGATGGGCTAAGCA GTAGGCTATGCACCCTGGAG 60 349 
2 and 3* GATGGCCTCTCCCACCAC CTCCCTGTTGAGCTGCTCCT 60 574 
4 and 5* TCCAGGAGCAGCTCAACAG TCTTCTCCCAAGTTGGTTGG 60 680 
6* CAAGGTCGAGGGGGTTCT GTTTCTGACACACCCACAGG 60 351 
7 AAAACCTGCTGCCAGTTCAT CCCAAAAGGGACAAAGTCCT 60 437 
8 AAGGAACGCAGCACAGTCTC TGGTCTTCTGCACGTCTGTG 60 544 
9* ACTGATGGTACGTGGCCTCT CGTCCATGCGTAGAAGGAGT 60 567 
11 and 12* CATTGGTGATTCTGCTGACC CTCAGCTTGAGCCAGTCCT 63 695 
13 and 14* GAGCCCTTTCTCCCTGAGAT GGTTGTAGCGGAACTTGCTC 60 623 
15* GCCTTCTCCCTCATCAGCTC GTAGGCAGTGCCCTTCACC 60 399 
16* AATGCACCGGAGAACAGGT CCGCGAGTGTCACCTCTG 60 388 
17* CGTGGACCCTGAGGAGTG CCCTCCGGATGTAGTGTGTC 60 420 
18* CTCGATGGCAACCAGCTC CTAGGCAGGACCCCTCCTC 60 451 
19* CAGGAGGGGCTCCAGTCTA ACAGAGCAGTCACCCACACA 60 336 
*primers originally reported by Vithana et al.1 
SUPPLEMENTARY TABLE S2: In Silico Analysis of the Effect of Novel SLC4A11 Missense 
Variants Identified in the Current Study.  
DNA level SNP&GO2 MutPred3 PROVEAN4 SIFT5 PolyPhen26 
Mutation 
taster7 
Overall 
classification 
c.1237G>A Disease 
Probably 
disease causing 
Deleterious Damaging Damaging 
Disease 
causing 
Pathogenic 
c.2003T>C Disease 
Disease 
causing 
Deleterious Damaging Damaging 
Disease 
causing 
Pathogenic 
Using MutPred an overall probability score > 0.5 was considered as probably disease causing and a score > 0.75 
was considered as disease causing. NM_032034.3 and; NP_114423.1 were used as reference sequences.
SUPPPLEMENTARY TABLE S3: In Silico Analysis of the Effect of Variants Potentially Affecting SLC4A11 Splicing Identified in the 
Current Study. All three algorithms predicted the presence of the known splice site in the wild type sequence and abolishment of the 
splice donor site in the presence of mutations. 
DNA level 
HSF8 [0-100] NetGene29 [0-1] NNSPLICE10 [0-1] MaxEntScan11 
Overall classification 
WT MUT 
Variation 
score 
Effect of the mutated allele WT MUT 
Variation 
score 
WT MUT 
Variation 
score 
c.1216+1G>A 90.18 63.34 -29.76% Loss of splice site 0.86 <0.4 -53.5% 8.99 0.81 -90.99% Pathogenic 
c.2240+5G>A 87.83 75.66 -13.86% Loss of splice site 0.97 <0.4 -58.8% 9.3 -2.95 -131.72% Pathogenic 
Abbreviations: HSF, the Human Splicing Finder; MaxEntScan, the maximum entropy model; WT, wild type; MUT, mutant. NM_032034.3 and NG_017072.1 were used as the 
reference sequences.  
The score variation difference between wild type and mutation of more than 10% for HSF and 30% for MaxEntScan and NNSPLICE was considered as resulting into splicing 
defect 8. 
 
 
 
 
 
SUPPLEMENTARY FIGURE S1. Targeted next generation sequencing of cDNA 
spanning SLC4A11 exon 16 and 17.  
(A) Aberrant splicing in a carrier of the c.2240+5G>A showing a mix of transcripts 
involving insertion of 6 bp and retention of intron 16. In comparison analysis of intron 
16 in the control sample revealed only background noise (< 5 reads) (B) Reads with 
retained intron 16 contained the c.2240+5A variant (red arrow) confirming that only the 
mutant allele is transcribed. 
A)  
B) 
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